Here’s a list of impacted products.

U.S agencies and Indian authorities are working together to stop fentanyl before it enters the American market.

Late-stage GLP-1 candidates from Eli Lilly, Novo Nordisk and Amgen have a combined net present value of $68 billion.

New weight loss drug by Pfizer shows promising results in trial - Pfizer acquired the drug’s developer following a bidding ...

Thus far, Pfizer's obesity efforts have crashed and burned. Last year, the pharmaceutical giant threw in the towel on ...

Over the past four decades, rare disease drug development has evolved from a scientific aspiration into a central pillar of biopharmaceutical innovation. Regulatory reforms, scientific breakthroughs, ...

The Epstein files are a lot, and that’s before we get to Trump’s appearances in them. They present such a sprawling, sordid, ...

Discusses Integrated Prefillable Syringe Systems to Streamline Drug Development and Reduce Complexity February ...

Biomedicines is the latest biotech to mull going public as momentum for IPOs continues to build. | Clinical-stage antibody ...

A young dealer who has admitted selling class A and B substances to pay off his own drug debts may have been more heavily involved in the ...